Synimmune (Biotechnology) Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Synimmune (Biotechnology) General Information
Description
Operator of a biotechnology company intended to develop oncology products. The company's services provide research and development of immunotherapies, provides monoclonal TCR technology to facilitate the generation of novel tumor-specific TCRs for the development of adoptive T cell therapy, and also provides an antigen discovery platform for functional identification of neoantigens for the development of personalized cancer vaccines, enabling physicians and doctors to treat their patients with various types of cancer.
Contact Information
Corporate Office
- 865 Altaire Walk
- Palo Alto, CA 94303
- United States
Corporate Office
- 865 Altaire Walk
- Palo Alto, CA 94303
- United States
Synimmune (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 25-May-2021 | Completed | Out of Business | |||
| 1. Accelerator/Incubator | Completed | Startup |
Synimmune (Biotechnology) Patents
Synimmune (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2020192684-A1 | Therapeutic agent containing isolated recombinant oncolytic adenovirus and immune cells and use therefor | Inactive | 27-Mar-2019 | ||
| WO-2020038491-A1 | Isolated t-cell receptor, modified cell, encoding nucleic acid and use thereof | Inactive | 24-Aug-2018 | ||
| WO-2020038492-A1 | Therapeutic agent comprising nucleic acid and tcr modified immune cell and use thereof | Inactive | 24-Aug-2018 | ||
| WO-2019096115-A1 | Isolated t-cell receptor, cell modified by same, coding nucleic acids, expression vector, preparation method, pharmaceutical composition, and applications | Inactive | 14-Nov-2017 |
Synimmune (Biotechnology) FAQs
-
When was Synimmune (Biotechnology) founded?
Synimmune (Biotechnology) was founded in 2017.
-
Where is Synimmune (Biotechnology) headquartered?
Synimmune (Biotechnology) is headquartered in Palo Alto, CA.
-
What industry is Synimmune (Biotechnology) in?
Synimmune (Biotechnology)’s primary industry is Biotechnology.
-
Is Synimmune (Biotechnology) a private or public company?
Synimmune (Biotechnology) is a Private company.
-
What is Synimmune (Biotechnology)’s current revenue?
The current revenue for Synimmune (Biotechnology) is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process